Athersys Inc (ATHX) – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: April 2023
- Report Code: MLPH4263FSA
Athersys Inc (ATHX) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary therapies in the field of regenerative medicine. It is investigating its lead platform, MultiStem, a patented stem cell product for treating chronic conditions such as cardiovascular diseases, inflammatory and immune disorders, neurological, and pulmonary disorders. The company’s MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, traumatic brain injury, vascular disease, acute pulmonary distress, wound healing, organ reperfusion, bone marrow/hematopoietic stem cell transplantation, ischemic stroke, and autoimmune disease. The company's pipeline consists of therapeutic product development programs in multiple disease areas, through the application of proprietary technologies. Athersys is headquartered in Cleveland, Ohio, the US.
Scope
• Detailed information on Athersys Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Athersys Inc in the form of a SWOT analysis
• An in-depth view of the business model of Athersys Inc including a breakdown and examination of key business segments
• News about Athersys Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Athersys Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Athersys Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Athersys Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Plus Therapeutics Inc
SanBio Inc
Pfizer Inc
Pluri Inc
Lisata Therapeutics Inc
Caladrius Biosciences, 18301 Von Karma Ave., Suite 130, Irvine, California, United States
Arena Pharmaceuticals Inc
Plus Therapeutics Inc
SanBio Inc
Pfizer Inc
Pluri Inc
Vericel Corp
Cryo-Cell International Inc
Vericel Corp
Cryo-Cell International Inc
Arena Pharmaceuticals Inc
Caladrius Biosciences Inc
Mesoblast Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.